{
    "answer": "The Novartis Q4 2024 Condensed Financial Report \u2013 Supplementary Data does not explicitly state Cosentyx's immunology segment net sales for the full year 2024, how these results changed on a reported and constant currency basis compared to the full year 2023.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 4,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        880,
        2297,
        2784,
        3284
    ]
}